HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jed Black Selected Research

Sodium Oxybate (gamma Hydroxybutyrate)

1/2015A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
12/2010The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
1/2010Sodium oxybate is an effective and safe treatment for narcolepsy.
9/2009The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
7/2006Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
1/2006gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.
9/2005Narcolepsy-cataplexy: how does recent understanding help in evaluation and treatment.
11/2004A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jed Black Research Topics

Disease

12Narcolepsy
01/2015 - 10/2002
6Cataplexy
01/2015 - 10/2002
4Sleep Initiation and Maintenance Disorders (Insomnia)
06/2007 - 10/2002
2Obstructive Sleep Apnea
05/2006 - 10/2002
1Apnea
10/2008
1Bradycardia
01/2007
1Syncope (Fainting)
01/2007
1Mood Disorders (Mood Disorder)
05/2006
1Fatigue
05/2006
1Ulcerative Colitis
05/2006
1Headache (Headaches)
05/2006
1Duodenal Ulcer (Curling's Ulcer)
05/2006
1Nausea
05/2006
1Migraine Disorders (Migraine)
05/2006
1Dizziness (Lightheadedness)
05/2006
1Body Weight (Weight, Body)
05/2006
1Fibromyalgia (Fibrositis)
01/2006
1Muscle Weakness
09/2005
1Sleep Deprivation
09/2005
1Sleep Apnea Syndromes (Sleep Apnea)
01/2003
1Parkinson Disease (Parkinson's Disease)
10/2002
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
10/2002
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2002
1Nervous System Diseases (Neurological Disorders)
10/2002
1Disorders of Excessive Somnolence (Hypersomnia)
10/2002
1Sleep Disorders
10/2002
1Restless Legs Syndrome (Restless Legs)
10/2002

Drug/Important Bio-Agent (IBA)

8Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
01/2015 - 11/2004
5modafinil (armodafinil)FDA Link
09/2009 - 01/2003
4orexins (orexin)IBA
09/2005 - 10/2002
1OxygenIBA
10/2008
1indiplonIBA
06/2007
1Psychotropic Drugs (Psychoactive Drugs)IBA
10/2002
1HLA-DQ Antigens (HLA-DQ)IBA
10/2002
1human HLA-DQB1 proteinIBA
10/2002

Therapy/Procedure

1Continuous Positive Airway Pressure
05/2006
1Plasmapheresis
09/2005